Legal entity

Cass Review

Company

Every one of those 1 sits in a single category, regulation. American Society of Plastic Surgeons is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. Cass Review appears in 1 tracked Legal story from August 13, 2026.

Last mentioned: Aug 13, 2026

Entity pulse

Recent coverage · Cass Review

1 story
7 avg impact
0% positive
100% negative

Coverage balance Negative coverage leads. Negative coverage exceeds positive coverage by 100 percentage points.

  • 100% negative

Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.

What the coverage shows about Cass Review

Every one of those 1 sits in a single category, regulation. American Society of Plastic Surgeons is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. Cass Review appears in 1 tracked Legal story from August 13, 2026. The tracked stories average 3 original sources each.

Stories tracked
1
Sources per story
3

Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 19 Legal stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.

Coverage cohort

Appears alongside

Other entities that clear the same relevance threshold in stories also covering Cass Review. Shared-story counts are live from our verified record — not editorial picks.

Timeline

  1. Federal funding restrictions take effect

    Medicaid and CHIP stop covering puberty blockers, cross-sex hormones, and surgical procedures for minors, with a six-month taper for current hormone therapy patients.

  2. Trump announces funding cutoff on Truth Social

    President Trump called the treatments 'barbaric surgeries' and said the government would not pay for harms to minors.

Stories mentioning Cass Review 1

Regulation Negative

Trump Bars Federal Funds for Youth Gender Care in 2 Programs

Legal and compliance teams face a new federal directive ending Medicaid and CHIP coverage for minors' gender-affirming care on October 13, while states retain authority to spend their own funds. Expect litigation over CMS authority, equal protection, and Section 1557.

3 sources

Cass Review is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.

See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.